Non-Bone-Derived Extracellular Vesicles in Osteoporosis: Evidence Mapping and Nanomedicine Translation. [PDF]
Int J NanomedicineAn J +6 more
europepmc +1 more source
The clinical recognition, diagnosis and treatment of osteogenesis imperfecta: a case report and literature review. [PDF]
Int J Clin Exp PatholMa Y, Li Y, Lv R, Yang N.
europepmc +1 more source
Characterizing MicroPure ultrasound detectability of mineralization-related echogenic foci in regenerate bone during tibial bone transport. [PDF]
Front Med (Lausanne)Zhang Z, Li J, Wang D, Zhou H, Zhang Y.
europepmc +1 more source
Extracellular Vesicles as Immunomodulatory Mediators in Angiogenic-Osteogenic Coupling: Mechanistic Insights and Therapeutic Potential. [PDF]
Adv Healthc MaterJin R +7 more
europepmc +1 more source
Defining the dystrophic femoral neck in osteogenesis imperfecta: a radiographic and anatomical entity with diagnostic threshold. [PDF]
SICOT JGeorges S +5 more
europepmc +1 more source
Favorable aortic remodeling following type B aortic dissection in a patient with osteogenesis imperfecta. [PDF]
J Vasc Surg Cases Innov TechDavis C +3 more
europepmc +1 more source
Nature Reviews Disease Primers, 2017 Osteogenesis imperfecta is a common heritable connective tissue disorder. Nearly ninety percent are due to Type I collagen mutations. Type I-IV are autosomal dominant, and Type VI-XIII are autosomal recessive. They are Graded 1-5 based on severity. Genomic testing is done by collagen analysis from fibroblasts.
Nick Bishop +2 more
exaly +11 more sources
Related searches:
Osteogenesis imperfecta is a genetic disorder of increased bone fragility, low bone mass, and other connective-tissue manifestations. The most frequently used classification outlines four clinical types, which we have expanded to seven distinct types. In most patients the disorder is caused by mutations in one of the two genes encoding collagen type 1,
Frank, Rauch, Francis H, Glorieux
openaire +4 more sources